JP2015524843A5 - - Google Patents

Download PDF

Info

Publication number
JP2015524843A5
JP2015524843A5 JP2015527538A JP2015527538A JP2015524843A5 JP 2015524843 A5 JP2015524843 A5 JP 2015524843A5 JP 2015527538 A JP2015527538 A JP 2015527538A JP 2015527538 A JP2015527538 A JP 2015527538A JP 2015524843 A5 JP2015524843 A5 JP 2015524843A5
Authority
JP
Japan
Prior art keywords
compound according
piperidin
alkyl
amine
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015527538A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015524843A (ja
JP6193374B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/054715 external-priority patent/WO2014028479A1/en
Publication of JP2015524843A publication Critical patent/JP2015524843A/ja
Publication of JP2015524843A5 publication Critical patent/JP2015524843A5/ja
Application granted granted Critical
Publication of JP6193374B2 publication Critical patent/JP6193374B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015527538A 2012-08-13 2013-08-13 Gpr6モジュレーターとしてのキノキサリン誘導体 Active JP6193374B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261682704P 2012-08-13 2012-08-13
US61/682,704 2012-08-13
US201261696748P 2012-09-04 2012-09-04
US61/696,748 2012-09-04
PCT/US2013/054715 WO2014028479A1 (en) 2012-08-13 2013-08-13 Quinoxaline derivatives as gpr6 modulators

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017154601A Division JP6389933B2 (ja) 2012-08-13 2017-08-09 Gpr6モジュレーターとしてのキノキサリン誘導体

Publications (3)

Publication Number Publication Date
JP2015524843A JP2015524843A (ja) 2015-08-27
JP2015524843A5 true JP2015524843A5 (enExample) 2016-09-29
JP6193374B2 JP6193374B2 (ja) 2017-09-06

Family

ID=48998764

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015527538A Active JP6193374B2 (ja) 2012-08-13 2013-08-13 Gpr6モジュレーターとしてのキノキサリン誘導体
JP2017154601A Active JP6389933B2 (ja) 2012-08-13 2017-08-09 Gpr6モジュレーターとしてのキノキサリン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017154601A Active JP6389933B2 (ja) 2012-08-13 2017-08-09 Gpr6モジュレーターとしてのキノキサリン誘導体

Country Status (4)

Country Link
US (2) US9487526B2 (enExample)
EP (1) EP2882722B1 (enExample)
JP (2) JP6193374B2 (enExample)
WO (1) WO2014028479A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6193374B2 (ja) * 2012-08-13 2017-09-06 武田薬品工業株式会社 Gpr6モジュレーターとしてのキノキサリン誘導体
JO3466B1 (ar) 2013-12-20 2020-07-05 Takeda Pharmaceuticals Co مواد ضابطة لتترا هيدرو بيريدوبيرازينات من gpr6
WO2015123505A1 (en) * 2014-02-14 2015-08-20 Takeda Pharmaceutical Company Limited Pyridopyrazines modulators of gpr6
JP6484640B2 (ja) * 2014-02-14 2019-03-13 武田薬品工業株式会社 Gpr6のピラジンモジュレーター
EP3600312B1 (en) * 2017-03-26 2023-05-17 Takeda Pharmaceutical Company Limited Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of gpr6
EP4568668A2 (en) * 2022-08-11 2025-06-18 MapLight Therapeutics, Inc. Gpr6 inverse agonists
CN115636797A (zh) * 2022-10-19 2023-01-24 台州国赐医药技术有限公司 一种制备5,6-二氯-2,3-吡嗪二酸的方法
WO2025160132A1 (en) * 2024-01-23 2025-07-31 Maplight Therapeutics, Inc. Gpr6 inverse agonists

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US20070054916A1 (en) 2004-10-01 2007-03-08 Amgen Inc. Aryl nitrogen-containing bicyclic compounds and methods of use
EA015937B1 (ru) 2005-08-26 2011-12-30 Мерк Сероно С.А. Производные пиразина и их применение в качестве ингибиторов pi3k
WO2007125405A2 (en) 2006-05-01 2007-11-08 Pfizer Products Inc. Substituted 2-amino-fused heterocyclic compounds
HRP20131081T1 (hr) 2007-04-11 2013-12-20 Exelixis Inc. Kombinirane terapije koje sadrže hinoksalin inhibitor p13k-alfa za uporabu u lijeäśenju kancera
GB0710844D0 (en) 2007-06-06 2007-07-18 Lectus Therapeutics Ltd Potassium ion channel modulators & uses thereof
EP2173354A4 (en) * 2007-08-09 2011-10-05 Glaxosmithkline Llc CHINOXALIN DERIVATIVES AS PI3 KINASE INHIBITORS
KR102016889B1 (ko) 2009-06-12 2019-08-30 아비박스 조기 노화, 구체적으로 조로증을 치료하는데 유용한 화합물
JP2013526546A (ja) * 2010-05-13 2013-06-24 アムジエン・インコーポレーテツド Pde10阻害剤としてのヘテロアリ−ルオキシヘテロシクリル化合物
EP3318561B1 (en) 2010-05-26 2021-12-22 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
WO2012167423A1 (en) 2011-06-08 2012-12-13 Hutchison Medipharma Limited Substituted pyridopyrazines as novel syk inhibitors
EP2849849A1 (en) 2012-05-09 2015-03-25 Ion Beam Applications S.A. Method for compensating the deviation of a hadron beam produced by a hadron-therapy installation
WO2013169964A1 (en) 2012-05-09 2013-11-14 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
JP6193374B2 (ja) * 2012-08-13 2017-09-06 武田薬品工業株式会社 Gpr6モジュレーターとしてのキノキサリン誘導体
JO3466B1 (ar) 2013-12-20 2020-07-05 Takeda Pharmaceuticals Co مواد ضابطة لتترا هيدرو بيريدوبيرازينات من gpr6

Similar Documents

Publication Publication Date Title
JP2015524843A5 (enExample)
JP2016525075A5 (enExample)
JP2014526549A5 (enExample)
JP2013532727A5 (enExample)
NZ622769A (en) Benzothiazol-6-yl acetic acid derivatives and their use for treating an hiv infection
JP2017533968A5 (enExample)
JP2016525076A5 (enExample)
ME02729B (me) Indolski i indazolski spojevi koji aktiviraju ampk
JP2014507464A5 (enExample)
JP2011519854A5 (enExample)
JP2013528204A5 (enExample)
JP2013537203A5 (enExample)
JP2013530176A5 (enExample)
JP2014513110A5 (enExample)
JP2015535277A5 (enExample)
JP2013510125A5 (enExample)
JP2017502940A5 (enExample)
AR081072A1 (es) Derivados de 3,3-dimetil-tetrahidroquinolina, composiciones farmaceuticas que los contienen, metodo para prepararlos y uso de los mismos para el tratamiento de la diabetes, obesidad y dislipemia
JP2011513305A5 (enExample)
JP2013505969A5 (enExample)
JP2019081762A5 (enExample)
MY148375A (en) Delta and epsilon crystal forms of imatinib mesylate
NZ600801A (en) Substituted imidazopyridinyl-aminopyridine compounds
JP2016501250A5 (enExample)
JP2015522650A5 (enExample)